Larissa University Hospital
Larissa, Thesalia, 41110, Greece
NCT Number: NCT00600704
The investigators' hypothesis is that restriction of circulating fluids in comparison to a liberal fluid administration policy would lead to a reduction of allogenic red blood cells exposure in patients undergoing cardiopulmonary bypass (CPB) for primary coronary artery bypass graft supported by reinfusion of washed shed blood from thoracic cavities.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Larissa, Thesalia, 41110, Greece
192 patients operated under equal conditions were assigned prospectively and randomly either for a restrictive protocol for intravenous fluid administration (group A, 100 patients) or not (group B, 92 patients). Transfusion guidelines were common for the two groups. The volumes of intravenous fluids, priming, "extra" volume on pump and cardioplegic solution and the volume of urine were recorded. Net erythrocyte volume loss was calculated. The number of the transfused PRC was analyzed as a continuous variable. "Transfusion" was analyzed as a categorical characteristic. Analysis employed Student's two-tailed t-test, t-paired test and chitest.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Infusion of Hes 130/0.4 up to 500 ml until the beginning of Cardiopulmonary bypass
Free fluid infusion unless Hb< 6g/dl(allogenic blood use), until the beginning of Cardiopulmonary bypass
Time frame: 20 months
Larissa University Hospital
Other
Impact of Fluid Restriction Policy Added to Intra-Operative Cell Salvage in Reducing the Use of Red Cells in Cardiac Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05726019
Acute Coronary Syndrome, Arterial Occlusive Diseases
São Paulo, Brazil
View Trial DetailsNCT07230561
Arterial Occlusive Diseases, Arteriosclerosis
New Taipei City, Taiwan
View Trial DetailsNCT00489827
Angina Pectoris, Angina, Unstable
Karlskrona, Sweden
View Trial DetailsNCT04560309
Arterial Occlusive Diseases, Arteriosclerosis
Jakarta, Indonesia
View Trial Details